| P2093 | author name string | Li-Fong Seet | |
| | Tina T Wong | |
| | Branko Stefanovic | |
| | Li Zhen Toh | |
| | Stephanie W L Chu | |
| | Sharon N Finger | |
| P2860 | cites work | Transforming growth factor beta -inducible independent binding of SMAD to the Smad7 promoter | Q22254141 |
| | Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor | Q24321977 |
| | TGF beta signals through a heteromeric protein kinase receptor complex | Q24337608 |
| | Smad6 as a transcriptional corepressor | Q28138994 |
| | Differential inhibition of Smad6 and Smad7 on bone morphogenetic protein- and activin-mediated growth arrest and apoptosis in B cells | Q28142906 |
| | Control of Smad7 stability by competition between acetylation and ubiquitination | Q28212409 |
| | Valproic acid induces cutaneous wound healing in vivo and enhances keratinocyte motility | Q28484912 |
| | Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury | Q28569252 |
| | Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets | Q29615465 |
| | TGF-beta signaling and the fibrotic response | Q29620099 |
| | SPARC deficiency results in improved surgical survival in a novel mouse model of glaucoma filtration surgery | Q33535934 |
| | Transforming growth factor-beta1 up-regulation of human alpha(1)(I) collagen is mediated by Sp1 and Smad2 transacting factors | Q33805741 |
| | SMAD and p38 MAPK signaling pathways independently regulate alpha1(I) collagen gene expression in unstimulated and transforming growth factor-beta-stimulated hepatic stellate cells. | Q50781080 |
| | Novel insight into the inflammatory and cellular responses following experimental glaucoma surgery: a roadmap for inhibiting fibrosis. | Q51013571 |
| | Stimulation of Type I Collagen Transcription in Human Skin Fibroblasts by TGF-β: Involvement of Smad 3 | Q60537832 |
| | Cellular proliferation after experimental glaucoma filtration surgery | Q68254932 |
| | Clinico pathological correlation in eyes with failed fistulizing surgery | Q70925498 |
| | TGF-beta1, -beta2, and -beta3 in vitro: biphasic effects on Tenon's fibroblast contraction, proliferation, and migration | Q73535456 |
| | Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts | Q73628355 |
| | Localization of Smads, the TGF-beta family intracellular signaling components during endochondral ossification | Q77995318 |
| | Homeobox gene Prx1 is expressed in activated hepatic stellate cells and transactivates collagen alpha1(I) promoter | Q80763912 |
| | Antitumor histone deacetylase inhibitors suppress cutaneous radiation syndrome: Implications for increasing therapeutic gain in cancer radiotherapy | Q95781492 |
| | Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy | Q34150830 |
| | Histone deacetylase: a potential therapeutic target for fibrotic disorders | Q34257607 |
| | Activation of CDK4 gene expression in human breast cancer cells by the Brn-3b POU family transcription factor | Q34290271 |
| | Transforming growth factor β1 inhibits bone morphogenic protein (BMP)-2 and BMP-7 signaling via upregulation of Ski-related novel protein N (SnoN): possible mechanism for the failure of BMP therapy? | Q34408710 |
| | Validation of the glaucoma filtration surgical mouse model for antifibrotic drug evaluation | Q35016977 |
| | Identifying an uptake mechanism for the antiepileptic and bipolar disorder treatment valproic acid using the simple biomedical model Dictyostelium. | Q35041292 |
| | Role of transforming growth factor beta in conjunctival scarring | Q35052886 |
| | The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling | Q36294196 |
| | Smad3 is key to TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis. | Q36313734 |
| | Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein | Q36573904 |
| | How the Smads regulate transcription | Q37025325 |
| | Valproic acid activates the PI3K/Akt/mTOR pathway in muscle and ameliorates pathology in a mouse model of Duchenne muscular dystrophy | Q37150816 |
| | In vitro analyses of the anti-fibrotic effect of SPARC silencing in human Tenon's fibroblasts: comparisons with mitomycin C. | Q37295174 |
| | Dynamic interplay between the collagen scaffold and tumor evolution | Q37786073 |
| | Surgical management of glaucoma: a review | Q37984667 |
| | Valproic acid for the treatment of malignant gliomas: review of the preclinical rationale and published clinical results | Q38016227 |
| | Molecular basis of organ fibrosis: potential therapeutic approaches | Q38121751 |
| | Antifibrogenic effects of histone deacetylase inhibitors on pancreatic stellate cells | Q38297992 |
| | Epigenetic regulation of myofibroblast differentiation and extracellular matrix production in nasal polyp-derived fibroblasts | Q38466614 |
| | Specific interactions between Smad proteins and AP-1 components determine TGFβ-induced breast cancer cell invasion. | Q39290041 |
| | Valproate and bone loss: iTRAQ proteomics show that valproate reduces collagens and osteonectin in SMA cells. | Q39689799 |
| | Wound healing in glaucoma filtering surgery | Q39697792 |
| | The balance between acetylation and deacetylation controls Smad7 stability. | Q40435100 |
| | Role of Smad4 on TGF-beta-induced extracellular matrix stimulation in mesangial cells | Q40647152 |
| | TGF-beta1-mediated fibroblast-myofibroblast terminal differentiation-the role of Smad proteins | Q40676876 |
| | A nuclear antagonistic mechanism of inhibitory Smads in transforming growth factor-beta signaling | Q40768248 |
| | Myofibroblast differentiation by transforming growth factor-beta1 is dependent on cell adhesion and integrin signaling via focal adhesion kinase. | Q42435832 |
| | Comparison of trichostatin A and valproic acid treatment regimens in a mouse model of kidney fibrosis | Q42711032 |
| | Chronic administration of valproic acid inhibits activation of mouse hepatic stellate cells in vitro and in vivo | Q43231143 |
| | Histone deacetylase modulates the proinflammatory and -fibrotic changes in tubulointerstitial injury | Q43244113 |
| | Smad6 inhibits non-canonical TGF-β1 signalling by recruiting the deubiquitinase A20 to TRAF6. | Q43492573 |
| | The role of Smad3 in mediating mouse hepatic stellate cell activation | Q43657688 |
| | The effect of valproate on bone mineral density in adult epileptic patients | Q44842897 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P304 | page(s) | 321-334 | |
| P577 | publication date | 2015-10-27 | |
| P1433 | published in | Journal of Molecular Medicine | Q6295593 |
| P1476 | title | Valproic acid suppresses collagen by selective regulation of Smads in conjunctival fibrosis | |
| P478 | volume | 94 | |